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ABSTRACT 
The  role  of microtubules  in  the  thyrotropin-  or  adenosine  3',5'  cyclic  monophosphate 
(cyclic AMP)-stimulated  accumulation  of cytoplasmic  colloid  droplets  and  secretion  of 
iodine from  the  mouse  thyroid  gland  has  been  investigated  by  means  of different  classes 
of agents  that  affect the stabili  W  of microtubules.  The  onset of inhibition  of secretion  by 
colchicine, the uptake  of colchicine-aH by thyroid lobes,  and  the bindmg  of colchicine-3H 
to  thyroidal  soluble  protein  are  shown  to  have  similar  time  courses  Colloid droplet  ac- 
cumulation is also inhibited and does not readily resume upon removal of colchicine from 
the medium. This appears to be due to the slow washout of the drug (t½  ~-~ 7  hr). Thvroids 
contain  a  soluble colchicine-binding protein  that  resembles mmrotubule  proteins  of other 
tissues with respect to apparent K~ for colchieine, pH optimum, and stability characterisncs 
Colchicine analogues inhibit iodine secretion and  colchicine binding m  a  parallel manner 
and  as  a  function  of their  antimitotic  potencies.  Microtubule-stabilizing  agents  such  as 
hexylene glycol and  D20  also  inhibit  secretion.  Thus,  inhibition  of thyroid  secretion  by 
antimitotic  agents  appears  to  be  mediated  by- an  effect  on  microtubules.  The  inhiMtory 
locus of colchicine inhibition occurs  after the generation of cyclic AMP,  since stimulation 
of secretion by this nucleotide  is blocked  by  colchicine,  whereas  thyroid-stimulating  hor- 
mone-induced  accumulation  of  cyclic  AMP  is  not  affected.  Thus,  the  functmning mi- 
crotubule appears to play a  role in the induction of colloid endocytosis. 
INTRODUCTION 
The  bulk  of  the  thyroid  hormone  and  organic 
iodine  present  in  thyroid  glands  is  stored  in  the 
follicular lumen  of the  gland  in  the  form  of  19S 
thyroglobulin (tool wt ~.~670,000)  and related pro- 
teins  of both  smaller  (t2S)  and  greater  (27-37S) 
size (1).  Oll the other hand,  the bulk of the circu- 
lating  organic  iodine  exists  in  the  form  of iodo- 
amino acids derived hydrolytically from the above 
iodinated  proteins.  Although  other  pathways  of 
hormone  secretion  have  not  been  ruled  out,  the 
present  concept for activation of thyroid  secretion 
by  thyroid-stimulating  hormone  (TSH) ~ involves 
the following steps  (a) TSH combines with a mem- 
brane receptor and activates the membrane-bound 
adenylate  cyclase (2,  3).  (b)  The increased  intra- 
1 Abbrevzations  used  include:  cyclic  AI',IP,  adenosine 
3~,5 r cyclic monophosphate;  dibutyryl  cyclic AlXlP, 
N~-2-O-dibutyryl-adenosine  3 t, 5 r  cyclic  monophos- 
phate; SP),IG,  0.25 ~  sucrose,  10 m~ Na phosphate, 
pFI 7.0,  10  ima  l~lgC12,  and  0.1  rmt  GTP  solution; 
~P2~IO, the  same  buffer  without  sucrose,  TSH,  thy- 
roid-stimulating hormone. 
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phate  (cyclic AMP)  then  activates colloid endo- 
cytosis. (c) This is followed by fusion of the colloid 
droplets  with  lysosomes,  intracellular  digestion, 
and release of thyroid hormone (4).  We have re- 
cently shown that colchicine, and other agents that 
can disaggregate microtubules, inhibit TSH- and 
N6-2-0-dibutyryl-adenosine  3P,5  '  cyclic  mono- 
phosphate  (dibutyryl  cyclic  AMP)-stimulated 
colloid  droplet  formation  and  131I release.  We 
therefore  suggested  a  role  for  microtubules  in 
thyroid  secretion  (5)  The  present work  extends 
this proposal and  provides further evidence that 
colchicine-induced inhibition of thyroid hormone 
release is caused by an effect on microtubular pro- 
tein  and  that  the  microtubule-dependent  step 
occurs  beyond  the  stage  of cyclic AMP genera- 
tion. 
:METHODS 
Thyroid secretion was studied in vitro by use of the 
mouse  thyroid  system  previously  described  (6). 
Thyroid gIands were labeled with  131I for  2  hr in 
vivo,  removed  on  the  trachea,  and  incubated  in 
Earle's solution for 4-6  hr.  Where specified, glands 
were  preincubated for  2  hr  with  colchieine or  an 
analog  and  were  then  transferred  to  a  new  flask 
containing the same concentration of the agent and 
TSH  or cyclic AMP. The fraction of the total thy- 
roldal  1~iI released was calculated from the radio- 
activity of the thyroid and that of an aliquot of the 
medium after incubation. 
Colloid  droplets  were  counted  using  previous 
criteria  (7)  in thyroids  fixed  in  Bouin's  solution, 
embedded in paraffin, and sectioned at 6  it. Values 
are reported either as the number of droplets per 50 
follicles or as the number of droplets per  100 nuclei 
(25 folhcles were counted in the latter case). 
Thyroidal  cyclic  AMP  levels  were  determined 
using  the  protein  binding  method  of  Gilman  (8) 
modified in that thyroids were homogenized in 50% 
glacial  acetic  acid,  centrifuged,  and  cyclic  AMIP 
content was  determined  in  aliquots  of the  super- 
natant  solution  after  drying.  For  analysis of cyclic 
AMP, thyroids were preincubated on the trachea for 
2  hr  as  in  secretion experiments,  and  the  thyroid 
lobes were then removed, pooled, and weighed on a 
torsion balance.  Lobes from two or  three mice per 
flask  were then incubated  1  hr  in  similar medium 
with  TSH  as  specified.  The  thyroids  were  then 
quickly homogenized in 300  /tl of cold 50% glacial 
acetic acid and the homogenate was centrifuged for 
1  rain  in  a  Beckman  Microfuge  (Beckman  Instru- 
ments, Inc., Fullerton, Calif ). Ahquots of 20-100 ttl 
were  dried  at  80°C  and  assayed  in  duplicate  for 
cyclic AMP  against a  standard curve run  simulta- 
neously. We would like to thank Dr. Eric Gruenstein 
for his help in these determinations. 
The  uptake  of colchicine-aH by  nlouse  thyroid 
glands was studied by incubating the thyroid on the 
trachea  in  Earle's  solution  containing  0.5  ttCi/ml 
colchicine-aH  at  the  specified  concentration  of 
eolchicme. After incubation for times varying from 
15 rain to 6 hr, the tissue was swirled for 30 see in a 
large volume of Earle's solution. The  thyroid lobes 
were  then  dissected  free,  weighed  on  a  torsion 
balance, and dissolved in 0.5 ml of Soluene (Packard 
Instrument Co., Downers Grove, Ill.)  in a  scintilla- 
tion vial.  15  ml of Bray's solution were then added 
and  the  radioactivity was  determined.  Quenching 
was corrected for by use of an internal standard and 
results are  expressed as picomoles of colchicine per 
milligram of thyroid tissue. 
Binding of colchicine-aH to soluble thyroid protein 
was studied using the  100,000  g  (1  br)  supernatant 
solution of obvine thyroid gland homogenized in  3 
vol of a  sohuion of 0.25  M sucrose, 10  mM Na phos- 
phate, pH 7.0,  10 mM MgCI2,  and 10  .4 M guanosine 
triphosphate  (GTP)  (SMPG)  at  2°C  (5).  Pellets 
contained  less  than  10%  of  the  total  colehicine 
bound by crude homogenates and were not studied 
With  pooled  mouse  thyroid  glands,  homogenate 
concentrations of 100 mg of tissue per ml of medium 
were used. The supernatant solution was either used 
directly or frozen at  --30°C. There was  no loss  of 
activity  after  1 wk.  Usually 0.45  ml  of the  SMPG 
thyroid supernatant solution was incubated at  37°C 
with  0.05  ml  of  H20  containing  2.5  ttCi/ml  of 
colchicine-3H  and  10  times  the  desired  colchicine 
concentrations  After incubation,  tubes were cooled 
rapidly  to  0°C  and  protein-bound  colchicine was 
assayed by the I)EAE  cellulose filter disc method of 
Weisenberg  et  al.  (9).  For  consistent  results,  two 
superimposed filter discs were used. The discs were 
prepared  by  passing  2.5  ml  of  10  mM  phosphate 
buffer,  pH  7.0,  with  10  rr~  MgCle  and  10  .4  ~t 
GTP  (PIG)  through  the filters with mild suction, 
being  careful  not  to  dry  the  filters  by  prolonged 
suction.  The degree of wetting determines tile sub- 
sequent filtration rate,  and had to be adjusted such 
that  the  time  required for subsequent filtration by 
gravity  was ~  8  mln  and ~  30  miI1  Successive 
additions to the filter chirrmeys were  1 ml of PMG 
with 1 - 10  -5 M colchicine, 0 1-0.2 ml of sample, and 
4  r~fl of PMG  with  10  _5  M colchicine,  all  at  2°C 
After gravity filtration, filters were washed four times 
with 4 0 ml of PMG at 2°C by suction and counted 
in  6  ml  of Bray's  solution.  Background binding of 
free colchicine was determined by assaying a  similar 
aliquot  of SMPG  containing  colchicine-3I-I  but  no 
protein;  this  usually  was  0.05--0 10%  of  the  total 
radioactivity present. In the presence of colehicine- 
binding  protein,  5-8%  of  labeled  colchicine was 
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maportant only at iow activities or when binding was 
markedly decreased  The  coefficient of variation on 
10  aliquots from the same sample  assayed simulta- 
neously was 1.2%  Results are expressed as picomoles 
of coIchicme bound  per  milhhter since the protein 
of  the  supernatant  solution  consisted  primarily  of 
thyroglobutin and varied between 20  and 40 mg/ml. 
Purified thyroglobuhn itself does not hind colchicme 
RESULTS 
Time Course of Colchiclne-Induced 
Inhibition of Thyroid Secretion 
In an earlier report, we found that the inhibitory 
effect of eolchlcine on iodine secretion showed an 
inverse time-concentration relationship. Thus, low 
concentrations of colchicine required 2-4 hr of pre- 
incubation  to  produce  maximum  inhibitory 
effects, whereas  immediate effects occurred  only 
with high  concentrations  (5).  The  slow  onset of 
colchicme effects, and the importance of preineu- 
bation,  are  depicted  in  Fig.  1.  With  1.10  -5  to 
1.10  -4 coichicine, rapid inhibition of mdine secre- 
tion can be obtained but such inhibinon is incom- 
plete  Even 1 • 10  -a colchicine does not abolish the 
formation  of  cotloid  droplets  (see  below)  when 
added simultaneously with TSH  To obviate possi- 
ble  nonspecific  effects  such  high  concentrations 
were not used. 
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stimulated release of  isiI from prelabeled mouse thy- 
roids  were  obtained  from  dose-inhibition curves  at 
various preincubation times  (5). 
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FmUR~ e  Failure of  reversal of  colehieine inhibition 
of TSH-stmlulated colloid droplet accumulation  The 
response to a  I  hr exposure to a~.5 munits/ml of TSH, 
added at ~, %.5, or 8 hr, was determined. ZX  =  5.10  -6 M 
eolchieine present for the first 8 hr and absent there- 
after. O  =  control medium without eolehieine. Pre- 
incubation was for ~ hr, and the ~ Jar point represents 
the baschne  droplet  count.  VMues  are  the  means 
=t=  SE  of three thyroids per group. 
Once mouse glands have been exposed to  col 
chicine,  subsequent incubation  in  colchicine-free 
media  does  not  reverse  the  inhibitory  state  for 
periods up to 6 hr as shown in Fig. 2.  Here the col- 
loid droplet response to TSH is used as an index of 
secretion  After 2 hr of preincubation the thyroids 
contained very few colloid droplets in either control 
or colchicine-treated tissues  The response to TSH 
was markedly attenuated bv  5-10-6 ~a  colchicine 
(3-hr points).  Incubation was  continued without 
colchicine, but despite this, glands that had been 
treated with colchlcine continued to be unable to 
respond to TSH for as long as 5 hr (8 hr point). In 
fact,  inhibition was more nearly complete at  the 
later  intervals.  The  decrease  of  the  droplet  re- 
sponse occurring with  time  in  the  control curve 
was variable  and  did  not occur  in  some experi- 
ments  The reason for this variability is not known. 
This poor reversal of the colchicine effect is in ac- 
cord with findings on other systems (11-13). 
In contrast to the above findings, once the TSH- 
stimulated  response  had  been  initiated,  the  in- 
hibitory effect of colchicine was slow to  manifest 
itself. This is depicted in Fig.  3  where the colloid 
droplet  response  is  shown  when  colchicine  was 
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have been complete if colchicine had  been added 
before TSH  (Fig.  2)  (5),  the droplet count was re- 
duced  by  only  about  50%  in  the  presence  of 
1 • 10  -~ ~ colchieine. Thus, inhibition of a secretory 
response  already initiated  by TSH requires more 
time than that required to block initiation of endo- 
cytosis. 
The  possibility  had  to  be  considered  that  the 
slow  onset  of inhibition  produced  by  colchicine 
was due to either a  slow rate  of penetration  or a 
slow rate of binding of the drug (14).  Fig. 4 shows 
data for the uptake  and  washout of colchicine-bH 
by mouse  thyroid glands  in vitro. The colehicine 
uptake  curves  (Fig.  4  A)  are similar to those ob- 
tained  with  beef  thyroid  slices  (5),  except  that 
steady-state  colchicine concentrations  are higher. 
Mouse thyroids rapidly (30 rain)  attain the colchi- 
cine  concentrations  of  the  surrounding  medium 
(indicated  by horizontal  bars)  and  then accumu- 
late the drug more slowly. In separate experiments 
the fraction of total mouse thyroid colchieine that 
was bound  to  protein  during  the first  15-60  rain 
amounted to ~25 %  when the external concentra- 
tion was 5.10 -6 ~. As in the case of KB cells (14), 
the rate  of attaining  equilibrium is concentration 
dependent. 
The washout of colchicine-~H from equilibrated 
mouse  thyroid  glands into  colchincine-free media 
shows  at  least  two  components  (Fig  4  B).  The 
slow  component  has  a  half-life of ~,7  hr.  A  bl- 
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Uptake  and  washout  of  eolchicme-bH  by 
mouse  thyroid  glands  in  vitro.  (A)  Uptake  of  eol- 
chieine-~H  at intervals ranging from  15  rain  to 6  hr 
from  medium  containing  5.10  -7 M or  5.10  -6  ~  col- 
chlcine.  (B)  Amount  of  colchicinebtt  remaining  in 
thyroids incubated 2 hr in 5-10  -~ ~  colchicine-SH  and 
transferred  at  time zero to colchicine-free media.  All 
values  are  the  mean  :t:SE  for  three  thyroids.  The 
horizontal  fines  indicate the  colchicine concentration 
of the medium  (assuming specific  gravities of  1.0). 
phasic loss of colchicine has also been shown in sea 
urchin eggs (15).  Extrapolation and subtraction of 
the slow component from the early time points sug- 
gests  the  presence  of  a  rapidly  lost  component 
which may represent the unbound  colchicine-bH. 
It is approximately equal to that which would be 
present in the tissue water at the concentration of 
the loading medium (see Fig. 4 A). Thus, both in- 
ward  and  outward  movement  of free  colchicine 
across the thyroid ceil membranes occurs rapidly. 
The slower phase of uptake  and release of colchi- 
cine is most likely related to the slow rate of bind- 
ing (see below) and may explain a part of the slow 
onset and reversal of colchicine-induced inhibition 
of secretion. However, at some concentrations (e.g. 
5-10-6M),  the  temporal  discrepancy  between 
binding  of colchicine  and  inhibition  of secretion 
(compare Figs. 4 A  and  1) suggests that other fac- 
tors must also play a role. 
Zocalization of the Colchicine Inhibition 
Colchicine blocks  the stimulating  action  of di- 
butyryl  cyclic AMP  on  181I release while adenyl 
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Effects of Colchwzne  on Cychc  A3lP-Stzmulated  lalI Release  by Mouse  Thwo~d~ I~z VitTo 
Per cent of thytoldal taII release 
Colchicme  Basal  3 rex* cyclic AMP  10 msx cyclic ANIP 
None  2.7  ::k  0  9  20  0  =t=  1  2  27  7  =t=  0.8 
2  X  10  -7  16  :t=03  15  4  =t=  1  1  22  6  =t=  0  5 
(20%)  06%) 
2  X  10  -6  2  9  =I=06  60  ±06  11  8  :t=  1  3 
(82%)  (65%) 
Thyroids were labeled m  vivo for 2  hr with 131I, preincubated  m  vitro for 2  hr with 
colchicine at the specafied concentration,  and incubated in slmllar media with cyclic 
AMP added as noted. The value an parentheses is the per cent of mhibmon  calculated 
by comparing the cyclic AMP-stimulated increment in I~I release to that found with- 
out colchicine  All values  are means  =t=sn of three to five thyroids. 
TABLE  II 
The Effect of Colchzc*ne  on Basal and  TSH-Stzmulated  Cych.  AzlIP 
Levels  ~n ,~louse  Thy~ozds In  Vzt~o 
Cvchc AI~IP 
Colchicme  Basal  Colchiclne  TStt  TSJcI +  colchlcine 
M  pmolex/n,~ 
1X  10  -~  0.8  -4-  0.2  1.14-  03  66  :~  1.0  66  ~  1.1 
1XIO -~t  06  4-0.1  08  ~  0.2  62  =t=0.8  8.2  i  15 
Thyroids were preincubated m  Earle's solution with colchicine for 2  hr and then in- 
cubated in similar media with 2 5 munits/ml TSH  for 1 hr  All values  are  the means 
-4- SE of three or four flasks containing two or three mouse thvrmds 
cyclase  and  phosphodiesterase  activities  are  not 
affected (5)  Since dibutbwyl cyclic AMP  can func- 
tion  as  a  phosphodlesterase  Inhibitor  (16),  and 
since  the  mouse  thyroid  gland  responds  well  to 
cyclic  AMP  (6,  17),  the  effect  of  colchicine  on 
cyclic AMP-stimulated  mI release was studied  As 
shown in Table  I,  colchicine inhibited the action 
of cyclic AMP  on mI secretion  There was shghtly 
tess inhibition at the higher concentration of cyclic 
ANiP  Thus,  the  inhibitory  locus  for  colchmme 
must lie after the generation of cyclic AMP. 
Since  measurement  of  adenylate  cyclase  ac- 
tivity  does  not  necessarily  reflect  tissue  leveIs  of 
cyclic AMP,  it was important to know whether or 
not  colchicine  could  influence  these  levels  in 
thyroid  tissue  It  is  known  that  TSH  increases 
tissue levels of cyclic AMP  (18,  19).  As shown in 
Table  II, TSH  produced an 8- to  10-fold increase 
in the cychc ANIP concentration of mouse thyroids 
stimulated in vitro  Preincubation in large concen- 
trations  of colchicine, which markedly  inhibit the 
subsequent  secretory  or  colloid  droplet  response 
(Fig  2),  did  not  influence  the  response  of  the 
cvchc AMP  levels to TSH 
Properties of Colchieine-Binding Protein 
If  colchlcine  inhibition  of  thyroid  secretion  is 
mediated  through  binding  to  microtubular  pro- 
tern,  it  should  be  possible  to  correlate  effects on 
this process with effects on laq release  Binding of 
colchicine-~H  to  a  6S  thyroidal  protein  has  been 
demonstrated  (5)  Binding  of  colchicine-:H  can 
also be demonstrated using the high speed super- 
natant  of  thyroid  homogenates  The  bi~ding  of 
colchicme as a  function of time and concentration 
at 37°C is shown in Fig  5  There was no significant 
binding  at  2°C.  The slow approach  to the steady 
state, particularly at low colchicine concentrations, 
resembles the uptake  of colchicine-SH and the on- 
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FmURE 5  (A)  Cotchicine-3H binding to soluble pro- 
tein from beef thyroid as a function of time for various 
colchMne concentrations.  (B)  Double  reciprocal plot 
of bound colchicine vs. medium concentration for 30, 
60,  and  1~0 rain taken from the data of Fig. 6 A. 
set of secretory inhibition observed in intact thyroid 
glands  (Figs  1, 3)  (5)  Reciprocal plots of steady- 
state  amounts  of bound  colchicine vs.  concentra- 
tion  reveal  an  apparent  Km  of  2-4-10-6M  in 
several experiments.  It is unlikely,  however,  that 
this binding system obeys simple first order kinetics 
(with  respect  to  colchicine)  since  apparent  Km 
values calculated for shorter binding times are as 
great as  l • l0  -~ M (Fig.  5 B). The relatively rapid 
decay of the binding site (see Fig. 6)  and the sup- 
posed protection of colchicine-binding proteins by 
colchicine  may  well  account  for  this  kinetic  be- 
havior. 
The pH  optimum  of colchicine binding  to the 
high  speed  supernatant  solution  of  beef  thyroid 
glands ranged from 6 7 to 7.1  in phosphate,  imida- 
zole, or Tris-maleate buffers. This optimum is like 
that reported by Wilson for the binding protein of 
chick brain  (20). 
The stability of the binding site was measured in 
protein that had been incubated for varying times 
at 37°C or 2°C and  then  allowed to bind  colchi- 
cine-3H for 60 min at 37°C. As shown in Fig. 6, the 
loss of ability to bind eolchicine was more rapid at 
37°C than at 2°C  Half-lives at  2°C  ranged  from 
4 to 9 hr,  whereas those at 37°C ranged from  1.9 
to 3.1  hr.  It has been shown that maximal protec- 
tion of the colchicine binding site of the brain pro- 
tein is afforded when bogh Mg  ++ and 1 - 10--~M GTP 
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~OraRE 6  Decrease in colchicine-3It binding to soluble protein from beef thyroid as a function of time 
and conditions of iucubation.  Thyroid supernatant  solutions were prepared  in sucrose-phosphate,  and 
1.10  -2 ~  of Mg  ++ and/or  1.10  -4 M were GTP added as indicated  Samples were incubated at ~o or 
S7°C. Colchicine3H binding was measured with 5-10  -6 ~  colchicine for 1 hr at 37°C at the end of the 
preincubation period. All points are duplicate assays. 
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Fm~  7  Effect of hexylene glycol (A) and D~O  (B) 
on basal and TSlI-stimulated  ialI release from mouse 
thyroids labeled for ~ hr in vivo and incubated for 4 hr 
in vitro  The concentration of TStI used in all cases  is 
5 munits/ml. Each point is the mean =t=s~ of four or 
five thyroids. 
are present  (9,  20)  As shown in Fig. 6, the major 
contribution to the  stability of thyroid colchicine- 
binding activity derived from Mg  ++  rather  than 
GTP.  Binding  activity did  not  always  decay  ex- 
ponentially at longer preincubation  times. Extrap- 
olation of the decay curves  to  zero  time  (20)  re- 
veals that the various deletions from the incubation 
medium did not significantly influence the initiat 
binding of colchieine-3H but acted primarily on the 
rate of decrease of binding. 
Certain  other reagents  have been  stated  to  in- 
fluence the stability or binding of colchicine to the 
binding protein  (9,  20).  However, with the crude 
thyroidal  binding  protein,  ascorbic  acid,  dithio- 
threitol, sodium glutamate, or  KC1  were without 
effect. 
Other Antimitotic Agents 
Colchicine,  which  disaggregates  microtubules, 
and  vinblastine,  which  leads  to  the formation  of 
paracrystalline  aggregates  of  microtubules,  both 
inhibit iodine secretion from the thyroid gland (5). 
Another class of compounds,  typified by hexylene 
glycol  (2-methyl-2,4-pentanediol)  and  by  D~O, 
interferes  with  a  microtubule-dependent  process 
(mitosis)  by  stabilizing  microtubules  (21-23).  If 
thyroid secretion were indeed dependent not only 
on intact microtubules but also  on  their  ability to 
rearrange,  etc.,  then  hexylene  glycol  and  D20 
might be expected to inhibit thyroldal 131I release 
As shown in Fig  7,  this was found  to be the case 
over the  concentration  range  0 5-2.0%  hexylene 
glycol and at  >25%  D20 in the medium  Hexyl- 
ene glycol caused a  slight increase in basal release 
of mI,  which  we  interpret  as  indicative of tissue 
damage (6)  70% DeO caused no such damage. No 
preincubation was required to achieve this inhibi- 
tion with either agent  Colloid droplet accumula- 
tion  was  inhibited  as  well as  131I release.  Thus, 
colchicine,  vinblastine,  and  DeO  and  hexylene 
glycol, which are believed to  affect microtubular 
function by different mechanisms,  all mbibit thy- 
roid secretion. 
Another  approach  in  relating  the  antimicro- 
tubular acUvity to binding of cotehicine to protein 
is  made  possible  by  the fact  that  the  antimitotic 
and  antitumor  activities  of numerous  colchicine 
analogues  have  been  quantified  (24)  For  this 
reason  we  have  compared  such  analogues  for 
their ability to influence iodine secretion from the 
thyroid on the one hand and binding to thyroidal 
protein  on  the  other.  Binding  of  analogues  was 
measured  by  their  ability  to  prevent  binding  of 
colchicine-~H.  In  Table  III  are  listed  various 
TABLE III 
Comparison o] the Potency of Colchieine Analogs on 
Inhzbmon o¢ Thyroid Sec~etzon and Binding of 
Colehzczne-3H to  Thyrozd Protein 
50% inhlbztory *  Colchlclne*~H 
concentration  on z~tI  binding 
Agents  release  (% of control) 
M 
Colchicme  2  X  10  -7  27  5 
Colcemid  6  X  10  -7  34.7 
N-Acetyhodo-  1  X  10  -~  57.5 
colehinol 
Colchiccine  3  X  10  -5  88.5 
Colchicoside  No effect at  96.4 
3  X  10  -4 
* Preincubation  time of 2 hr in all experiments. 
$ Control  binding  (100~)  was  determined  by in- 
cubation  of beef thyroid SI~IPG supernatant  solu- 
tion with  1 X  10  .6  M,  colchicine-~H for  1.5  hr  at 
37°C.  The  various  analogs  were  added  shnulta- 
neously  at  1  X  10  -6  M. 
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antimitotic activity (24)  There is a striking" corre- 
lation of the antisecretory potency with the ability 
of these analogues to interact with the colchicine- 
binding protein. These data  thus provide strong 
evidence that the antisecretory effects of colchicine 
are  operating  through  an  interaction with  the 
microtubular protein 
DISCUSSION 
Three major questions arise which can be answered 
with a decreasing level of certainty: (a)  Is the in- 
hibitory action of the  microtubule-active agents 
mediated through an action on the microtubule? 
(b) Is the inhibitory effect  on secretion specific to 
microtubules  or  colchicine-binding protein?  (c) 
What is the role of microtubules in thyroid secre- 
tion at the microscopic or molecular level? 
A  sine  qua  non  for the present discussion is  the 
need to establish that the colchicine-binding  pro- 
tein is,  in fact,  a  component subunit of micro- 
tubules. This has been widely assumed on the basis 
of colchicine effects on the state of aggregation of 
mitotic spindles and  certain other  microtubular 
structures  Actually, most of the evidence is indi- 
rect. Thus, colchicine binding  is high in tissues that 
have abundant microtubules and low in those that 
do not (25), and isolated mitotic apparatus prepa- 
rations are enriched in colchicine-binding  protein 
(15).  Moreover,  specific  removal of  the  central 
pair of microtubules from sea urchin sperm tails 
progressively removes  the  colchicine-binding ac- 
tivity from the sperm tails and is accompanied by 
a corresponding increase of such activity in the ex- 
tract (26)  More direct evidence derives from ex- 
periments of Kirkpatrick et al.  (22)  who showed 
that  the  major  protein  obtained  from  isolated 
brain microtubules characterized on the basis of 
ultrastructure behaves electrophoretically like the 
colchicine-binding protein isolated  directly from 
brain and has the same molecular weight Further- 
more,  antibodies  made  to  preparations  from 
Tetrahymena  cilia of the type that yield colchicine- 
binding protein  appear  to  combine with  intact 
bundles of microtubules (27).  Using another ap- 
proach, it has been shown that vinblastine-induced 
paracrystalline precipitates of microtubules  (28- 
30)  show in vivo radioautographic localization of 
eolchicine-"H (31)  The isolated paracrystals also 
have colchicine-binding  activity in vitro and have 
an amino acid composition similar to that reported 
for colchicine-bindmg  protein and other presump- 
tive microtubular subunits (32). 
The thyroid cell contains numerous, apparently 
unorganized,  cytoplasmic  microtubules (33).  It 
also  contains a  colchicine-bmding protein which 
resembles that of brain and other  tissues  on the 
basis of size  (6S)  and behavior on Sephadex  (5), 
the apparent K~ (Fig  5), the temperature and pH 
dependence, and the lability (Fig.  5) of colchicine 
binding  These  simiianties, taken  together  with 
the excellent correlation of the antimitotic potency 
of a  number of colchicine analogues with  their 
effect  on  both  secretion  and  colchicine binding 
(Table III), provide strong support for  the  pre- 
sumption that colchieine affects microtubular sta- 
bihty in the thyroid in a manner similar to that of 
other tissues. 
The likelihood that the effect  of colchicine on 
secretion operates through microtubules in no way 
rules out the possibility that there might be other 
actions of colchicine that could influence the secre- 
tory process.  In examining this question, it is im- 
portant  to  distinguish between  those  metabolic 
processes  commonly,  or  obligatorily,  associated 
with secretion, which might be influenced by inter- 
ference  with  microtubule  function,  from  other 
effects.  To this end we have recently shown that 
colchicine concentrations that completely inhibit 
iodine secretion or colloid droplet accumulation do 
not  inhibit  the  TSt-I-stimulated  oxidation  of 
[1-14C~glucose, [6-1~C~glucose, or  [1-14CJpyruvate 
(34).  Very  large  concentrations  of  colchicine 
(1.10-2 M) may inhibit glucose oxidation (10), but 
such levels are ,~,104 times those reqmred  to in- 
hibit secretion and they have not been used in the 
present study. 
We have shown earlier that colchicine does not 
inhibit fluoride- or TSH-stimulated beef thyroid 
adeuylate  cyclase  or  the  cyclic  3s,5'-nucleotide 
phosphodiesterase  of  mouse  thyroid  glands  (5). 
The present results, showing no effect on colchicine 
on the tissue levels of cyclic AMP (Table II), are in 
accord with the above conclusions We have also 
been able to show that cotchicine has no effect on 
iodide transport by the mouse thyroid, nor on the 
in vitro uptake or short term conversion of 13II- to 
iodoamino  acids  (unpublished  observations)  It 
has  also  been shown that  hormone induction of 
mammary tissue dehydrogenases is not affected by 
colchicine (35). 
Since  membrane-stabilizing drugs  may  have 
marked  effects  on  secretory  processes  including 
those in the thyroid, it is possible that colchicine 
and  related  drugs  might  act  as  membrane sta- 
bilizers.  This would appear to be unhkely, how- 
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colchicine  and  the  fact  that  no  membrane  sta- 
bihzation has been found  in  the lysosomal mem- 
brane (36)  or the erythrocyte  (K. Matthews, per- 
sonal communication). The absence of a colchicine 
effect on adenylate cyclase, which is very sensitive 
to  membrane stabilizers  (37),  also  argues  against 
such an effect. 
It may  be concluded,  then,  that after stimula- 
tion  of the  TSH  receptor  the  early  formation  of 
colloid droplets and their intracellular accumula- 
tion is highly sensitive to inhibition by colchicine. 
The  participation  of microtubules in  this process 
may  be  considered  as  highly probable,  although 
the  nature  of  the  microtubular  contribution  to 
hormone secretion may be either active or passive 
(structural). 
Recewed for publieatwn  11  February 1972,  and m  rewsed 
fo~m 24 3£areh 1972. 
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